This company listing is no longer active
KBPH Stock Overview
Kyto Technology and Life Science, Inc. is a venture capital firm specializing in startups and early stage companies. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 2 more risks
Kyto Technology and Life Science, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.00 |
| 52 Week High | US$2.00 |
| 52 Week Low | US$1.00 |
| Beta | 0.0054 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -95.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| KBPH | US Capital Markets | US Market | |
|---|---|---|---|
| 7D | 0% | 2.4% | 2.0% |
| 1Y | n/a | 55.8% | 32.4% |
Return vs Industry: Insufficient data to determine how KBPH performed against the US Capital Markets industry.
Return vs Market: Insufficient data to determine how KBPH performed against the US Market.
Price Volatility
| KBPH volatility | |
|---|---|
| KBPH Average Weekly Movement | n/a |
| Capital Markets Industry Average Movement | 3.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.9% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: KBPH has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine KBPH's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 1 | Paul Russo | www.kytotech.com |
Kyto Technology and Life Science, Inc. is a venture capital firm specializing in startups and early stage companies. Its investments are either in the form of secured convertible debt paying interest and offering a discount upon conversion to preferred shares, or directly into preferred shares. The firm seeks to invest in technology and life science companies.
Kyto Technology and Life Science, Inc. Fundamentals Summary
| KBPH fundamental statistics | |
|---|---|
| Market cap | US$16.33m |
| Earnings (TTM) | US$651.61k |
| Revenue (TTM) | n/a |
25.1x
P/E Ratio9,999x
P/S RatioIs KBPH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KBPH income statement (TTM) | |
|---|---|
| Revenue | -US$505.00 |
| Cost of Revenue | US$0 |
| Gross Profit | -US$505.00 |
| Other Expenses | -US$652.12k |
| Earnings | US$651.61k |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.04 |
| Gross Margin | 100.00% |
| Net Profit Margin | -129,032.08% |
| Debt/Equity Ratio | 0.0% |
How did KBPH perform over the long term?
See historical performance and comparison